Stage IVB Pancreatic Cancer Recruiting Phase 1 Trials for DB07232 (Veliparib)

IndicationStatusPhase
DBCOND0029409 (Stage IVB Pancreatic Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00576654Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by SurgeryTreatment